-
公开(公告)号：US08097635B2
公开(公告)日：2012-01-17
申请号：US12440807
申请日：2007-09-19
IPC分类号： A61K31/44
CPC分类号： A61K31/437 , A23G3/364 , A23G4/12 , A23L33/10 , A23V2002/00 , A23V2200/328 , C07D471/04 , Y10S514/866
摘要： An object of the present invention is to provide a safe and highly effective insulin resistance improving agent or therapeutic agent for type II diabetes. According to the present invention, an insulin resistance improving agent or a therapeutic agent for type II diabetes comprising a compound represented by general formula (I) (wherein R1, R2, and R3 are the same as or different from each other, and each represents lower alkyl, lower alkenyl, lower alkynyl, aralkyl, araryl, phenyl, or a hydrogen atom) or a salt thereof as an active ingredient can be provided.
摘要翻译： 本发明的目的是提供一种安全高效的胰岛素抵抗改善剂或II型糖尿病治疗剂。 根据本发明，提供一种胰岛素抵抗性改善剂或II型糖尿病治疗剂，其含有通式（I）表示的化合物（其中，R1，R2和R3彼此相同或不同，表示 低级烷基，低级烯基，低级炔基，芳烷基，芳芳基，苯基或氢原子）或其盐作为有效成分。
-
公开(公告)号：US20100093780A1
公开(公告)日：2010-04-15
申请号：US12440807
申请日：2007-09-19
IPC分类号： A61K31/437 , A61P3/10
CPC分类号： A61K31/437 , A23G3/364 , A23G4/12 , A23L33/10 , A23V2002/00 , A23V2200/328 , C07D471/04 , Y10S514/866
摘要： An object of the present invention is to provide a safe and highly effective insulin resistance improving agent or therapeutic agent for type II diabetes. According to the present invention, an insulin resistance improving agent or a therapeutic agent for type II diabetes comprising a compound represented by general formula (I) (wherein R1, R2, and R3 are the same as or different from each other, and each represents lower alkyl, lower alkenyl, lower alkynyl, aralkyl, araryl, phenyl, or a hydrogen atom) or a salt thereof as an active ingredient can be provided.
摘要翻译： 本发明的目的是提供一种安全高效的胰岛素抵抗改善剂或II型糖尿病治疗剂。 根据本发明，提供一种胰岛素抵抗性改善剂或II型糖尿病治疗剂，其含有通式（I）表示的化合物（其中，R1，R2和R3彼此相同或不同，表示 低级烷基，低级烯基，低级炔基，芳烷基，芳芳基，苯基或氢原子）或其盐作为有效成分。
-
搜索结果
2 条记录 (耗时 0.018 秒)
